Mayne Pharma manufactures and commercializes a diverse portfolio of branded and generic pharmaceutical products, focusing heavily on specialty therapeutic areas such as dermatology, women's health, and metabolic disorders. Prominent brand products in its commercial lineup include Nextstellis as an oral contraceptive, Doryx for acne treatment, and specialized topical dermatology treatments, alongside a broad suite of generic prescription medications and specialized oral drug delivery formulations marketed globally across retail and institutional pharmacy channels.